|
Science Friday > Archives > 2002 >
April
> April 5, 2002:
Hour One: Gene-Based Medicine
One often-stated goal of the Human Genome Project was
to provide medical researchers with information that would help them
create better medications. This week, scientists at the University of
Washington reported in the Journal of the American Medical Association
that people with a certain gene are more likely to have a bad reaction
to a commonly prescribed blood thinner than people without the gene.
In this hour, we'll take a look at the latest developments
in gene-based medicine. How can your genetic information be used to
make diagnosis easier and treatment better? Plus, genetic news in another
field -- rice.
Call in with your comments and questions at 1-800-989-8255, and share
your opinions online in our Listeners' Lounge (registration required).
Guests:
Rod Wing
Director, Clemson University
Genome Institute
Professor
Clemson University
Clemson, South Carolina
Robert Tepper
Chief Scientific Officer
Executive Vice President of Drug Discovery
Millennium Pharmaceuticals, Incorporated
Cambridge, Massachusetts
David Veenstra
Assistant Professor, School
of Pharmacy
University of Washington
Seattle, Washington
Janet Warrington
Senior Director, Health Management Research
Affymetrix, Incorporated
Santa Clara, California
Books/Articles Discussed:
Related Links:
UW
study links gene to success of a treatment for high blood pressure
Study
shows genetic variants put some patients at risk for dangerous drug
reactions Pharmacogenomics:
Medicine and the New Genetics
C&EN:
COVER STORY - PHARMACOGENOMICS
Pharmacogenomics:
The Promise of Personalized Medicine - A Review by: Laviero Mancinelli,
Maureen Cronin, Wolfgang Sadee
Pharmacogenomics:
A Public Health Perspective Editorial
PhRMA
Genomics: A Global Resource
This segment produced by: Annette Heist
| 
